IL2 and renal carcinoma: High dose of IL-2 induced striking responses in patients with metastatic melanoma or renal cancer, but unacceptable adverse effects such as capillary leak syndrome (the most severe side effect of IL-2), constitutional symptoms and renal dysfunction were also observed [76].